Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
format_facet:"Aufsätze"
topic_facet:"Phase: Phase 3"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=format_facet%3A%22Aufs%C3%A4tze%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+3%22&lookfor=%22Arthritis%22&type=Subject
/vufind/Search/Results?filter%5B%5D=format_facet%3A%22Aufs%C3%A4tze%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+3%22&lookfor=%22Arthritis%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=format_facet%3A%22Aufs%C3%A4tze%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+3%22&lookfor=%22Arthritis%22&type=Subject
PubPharm (3.053)
1
Pediatric Arthritis Study of Certolizumab Pegol : A Multicenter, Open-label Study to Assess the Pharmacokinetics, Safety and Efficacy of Certolizumab Pegol in Children and Adolescents With Moderately to Severely Active Polyarticular-course Juvenile Idiopathic Arthritis (JIA)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
2
Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthritis. : A Multicenter, Randomized Open-Label Study to Assess the Efficacy, Safety, and Pharmacokinetics of Upadacitinib With a Tocilizumab Reference Arm in Subjects From 1 Year to Less Than 18 Years Old With Active Systemic Juvenile Idiopathic Arthritis
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
3
Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis : A Phase 3b/4 Randomized, Double-Blind, Double Dummy, Active Comparator-Controlled Study, Comparing the Efficacy and Safety of Upadacitinib Versus Adalimumab in Subjects With Moderate to Severe Rheumatoid Arthritis on a Stable Background of MTX and Who Had an Inadequate Response or Intolerance to a Single TNF Inhibitor (SELECT- SWITCH)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
4
A Study to Assess the Long-term Safety, Tolerability, and Efficacy of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis : A Multicenter, Open-Label Extension Study to Assess the Long-Term Safety, Tolerability, and Efficacy of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
5
Study to Demonstrate the Efficacy, Safety and Tolerability of Intravenous Secukinumab up to 52 Weeks in Subjects With Active Psoriatic Arthritis : A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase III Multicenter Study of Intravenous Secukinumab to Compare Efficacy at 16 Weeks With Placebo and to Assess Safety and Tolerability up to 52 Weeks in Subjects With Active Psoriatic Arthritis
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
6
A Study to Evaluate the Pharmacokinetics, Efficacy and Safety of Intravenous Golimumab in Pediatric Participants With Active Polyarticular Course Juvenile Idiopathic Arthritis Despite Methotrexate Therapy : A Multicenter, Open-Label Trial of Intravenous Golimumab, a Human Anti-TNFα Antibody, in Pediatric Subjects With Active Polyarticular Course Juvenile Idiopathic Arthritis Despite Methotrexate Therapy
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
7
A Study of Guselkumab in Participants With Active Psoriatic Arthritis : A Phase 3b, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Subcutaneously Administered Guselkumab in Improving the Signs and Symptoms and Inhibiting Radiographic Progression in Participants With Active Psoriatic Arthritis
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
8
Guselkumab in Active Psoriatic Arthritis Participants With Inadequate Response/Intolerance to One Prior Anti-TNF Alpha Agent : A Phase 3B, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Guselkumab Administered Subcutaneously in Participants With Active Psoriatic Arthritis Who Had an Inadequate Response and/or Intolerance to One Prior Anti-Tumor Necrosis Factor Alpha Agent
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
9
A Study of Ustekinumab or Guselkumab in Pediatric Participants With Active Juvenile Psoriatic Arthritis : A Phase 3 Multicenter, Open-label Study to Evaluate the Efficacy, Pharmacokinetics, Safety, and Immunogenicity of Subcutaneously Administered Ustekinumab or Guselkumab in Pediatric Participants With Active Juvenile Psoriatic Arthritis (PSUMMIT-Jr)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
10
A Long-term Extension Study of Ustekinumab in Pediatric Participants : A Phase 3, Multicenter, Open-label, Basket, Long-term Extension Study of Ustekinumab in Pediatric Clinical Study Participants (2 to <18 Years of Age)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[306]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Medienart: Aufsätze
Filter aufheben
Thema: Phase: Phase 3
Medienart
Aufsätze
3.053
E-Artikel
3.053
E-Ressourcen
Zeitschriftentitel
2.484
WHO International Clinical Trials Registry Plat...
569
ClinicalTrials.gov
Thema
3.053
610
Phase: Phase 3
3.053
Study Type: Interventional
1.746
Recruitment Status: Not yet recruiting
536
Recruitment Status: Authorised-recruitment may ...
530
Arthritis
499
Recruitment Status: Completed
368
Arthritis, Rheumatoid
239
Medical Condition: Rheumatoid Arthritis
108
Medical Condition: Moderately to Severely Activ...
104
Arthritis, Psoriatic
95
Recruitment Status: Recruiting
70
Medical Condition: Psoriatic Arthritis MedDRA v...
57
Arthritis, Juvenile
49
Recruitment Status: Terminated
43
Medical Condition: Arthritis, Rheumatoid
42
Medical Condition: Rheumatoid Arthritis MedDRA ...
40
Medical Condition: Moderately to Severely Activ...
36
Medical Condition: Moderately to Severely Activ...
34
Medical Condition: Psoriatic Arthritis
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
1.686
2020-
1.346
2010-2019
21
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
2.955
Englisch
90
Unbestimmt
8
Spanisch
Haven't found what you're looking for?
Wird geladen...